ClinicalTrials.gg
Not yet recruitingNCT07847749WhiteLine_SUpdated Oct 1, 2026

Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis.

An interventional study of Anterior white-line advancement using an ABSORBABLE suture (POLYSORB 5-0). RED CODE. and Anterior white-line advancement using a NON-ABSORBABLE suture (POLYPROPYLENE 5-0). BLUE CODE. in Blepharoptosis, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Not yet recruiting at 1 site in Spain. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Not applicable, Interventional, and Treatment

Updated Oct 1, 2026Title changedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

What is the diagnosis and what treatment is indicated? The diagnosis is eyelid ptosis, which means drooping of the upper eyelid. This may reduce quality of life by affecting the upper visual field and interfering with daily activities such as driving and reading. It may also cause forehead muscle fatigue, neck pain, a sad or tired appearance, eyelid asymmetry, and forehead wrinkles.

The only treatment to correct eyelid ptosis is surgery. In the present case, the indicated procedure consists of reinserting the tendon of the upper eyelid levator muscle into the original position on the tarsus. This is performed using sutures to attach the tendon to the tarsus. Two types of sutures may be used: absorbable sutures, which are absorbed by the body over approximately 2-3 months, and non-absorbable sutures, which remain permanently in the eyelid because the body cannot break them down.

Why is this study being conducted? The surgery that participants will undergo is part of the standard treatment for eyelid ptosis. Both types of suture material used in this procedure are routinely used in clinical practice, meaning that either type could be used regardless of participation in the study.

Some previous studies suggest that non-absorbable sutures may maintain eyelid elevation better in the long term and reduce the need for further surgery compared with absorbable sutures. However, there is currently insufficient evidence to establish this with certainty. Most previous studies have evaluated patients who had already been treated rather than prospectively comparing both types of sutures through a randomized clinical trial, which may introduce bias when interpreting the results.

Therefore, there is currently insufficient scientific evidence to determine with certainty which suture material provides better results, and both materials continue to be routinely used in clinical practice.

The aim of this study is to compare both types of suture under controlled conditions through a randomized controlled trial, in order to determine the outcomes associated with each type of suture in the medium and long term.

How will the type of suture be determined? If a participant agrees to participate, the type of suture used during surgery will be assigned randomly by a computerized randomization system. Neither the participant nor the surgeon will be able to choose the type of suture.

Both suture materials are routinely used in clinical practice and are authorized for this type of surgery. The only difference between the two study groups will be the material used to attach the upper eyelid levator tendon to the tarsus.

Participants will not be informed which type of suture was used during surgery, although this information may be accessed if medically necessary.

What does the procedure involve? The surgery will be performed in an operating room by ophthalmologists specialized in eyelid surgery. The procedure will be performed under local anesthesia with light sedation. This is an outpatient procedure and does not require hospital admission. The procedure lasts approximately 45-60 minutes. If removal of excess skin is required in a particular case, this will be performed during the same procedure.

Anterior white-line (levator tendon) advancement through the skin produces a scar within the eyelid crease. This is generally a cosmetic and well-tolerated scar.

Five visits will be required for appropriate follow-up, which is the same number of visits that would be required without participation in the study: the initial visit, the day of surgery, and three follow-up visits at 2 weeks, 3 months, and 7 months. Participation in this study does not involve any additional risk from supplementary tests.

During the study, photographs of the periocular area and face will be taken to evaluate the surgical outcomes. These images will be treated as personal health data.

If a participant decides to participate, the participant will be asked to sign an Informed Consent Form. Participation will involve allowing information from the medical record to be collected, consenting to relevant clinical photographs, and attending the scheduled follow-up visits.

The study will be conducted at Hospital Rey Juan Carlos and aims to include 58 patients with the same condition.

02

Conditions studied

  • Blepharoptosis

Browse trials for

Keywords

  • blepharoptosis
  • ptosis
  • White Line Advancement
  • aponeurotic ptosis
03

In context

Blepharoptosis

76 studies on the registry are indexed under Blepharoptosis; 15 are open to participants now.

This study's planned enrollment of 58 is above the median of 50 across 57 interventional studies indexed under Blepharoptosis.

Browse Blepharoptosis studies →

Lead sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz is the lead sponsor of 76 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients (cases) must meet ALL of the following criteria to be included in the study:

  • Age >18 years.
  • Diagnosis of primary aponeurotic eyelid ptosis.
  • Upper eyelid levator muscle function of ≥12 mm.
  • Acceptance and signing of to participate in the study after having received adequate information.

Exclusion criteria

Exclusion Criteria:

Patients meeting ANY of the following criteria will not be eligible to participate in the study:

  • Diagnosis of eyelid ptosis of non-aponeurotic etiology.
  • Diagnosis of recurrent eyelid ptosis or previous surgical treatment for ptosis.
  • Known allergy or previous adverse reaction to any of the suture materials under investigation.
  • Medical or surgical history that, in the investigator's judgment, precludes participation in the study.
  • Participant with who is not using highly effective .
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Reproductive potential

Able to have children. For women this usually means from the first period until menopause, unless permanently unable to through surgery; for men, unless permanently sterile. Read who the line is about — participants, women, men, or their partners.

Criteria about it usually ask for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
58 participants (estimated)

Study arms

  • Active comparator
    Group A: ABSORBABLE suture (POLYSORB 5-0). RED CODE

    Procedure: Anterior white-line advancement using an ABSORBABLE suture (POLYSORB 5-0). RED CODE.

  • Experimental
    Group B: NON-ABSORBABLE suture (POLYPROPYLENE 5-0). BLUE CODE

    Procedure: Anterior white-line advancement using a NON-ABSORBABLE suture (POLYPROPYLENE 5-0). BLUE CODE.

Interventions

  • ProcedureAnterior white-line advancement using an ABSORBABLE suture (POLYSORB 5-0). RED CODE.

    A traction suture is placed in the gray line. A skin incision is made at the upper eyelid crease using a Colorado-tip electrocautery device. Dissection is performed through the orbicularis muscle to expose the superior tarsal border and approximately 2 mm of its anterior surface. Proximal dissection is then performed in the pre-Müller's muscle-conjunctiva plane to identify the white line. A double-armed, non-transfixing, absorbable POLYSORB 5-0 suture is placed through the anterior tarsus (1 mm from its superior border) and the exposed white line at the pupillary axis. The suture is temporarily tied to assess eyelid height and contour and then permanently tied once adequate positioning is confirmed. The skin is closed with a 6-0 non-absorbable monofilament suture.

  • ProcedureAnterior white-line advancement using a NON-ABSORBABLE suture (POLYPROPYLENE 5-0). BLUE CODE.

    A traction suture is placed in the gray line. A skin incision is made at the upper eyelid crease using a Colorado-tip electrocautery device. Dissection is performed through the orbicularis muscle to expose the superior tarsal border and approximately 2 mm of its anterior surface. Proximal dissection is then performed in the pre-Müller's muscle-conjunctiva plane to identify the white line. A double-armed, non-transfixing, absorbable POLYPROPYLENE 5-0 suture is placed through the anterior tarsus (1 mm from its superior border) and the exposed white line at the pupillary axis. The suture is temporarily tied to assess eyelid height and contour and then permanently tied once adequate positioning is confirmed. The skin is closed with a 6-0 non-absorbable monofilament suture.

06

What researchers measure

Primary outcomes

  1. Margin Reflex Distance 1 (MRD1)

    Time frame: 7 months postoperatively

Secondary outcomes

  1. Margin Reflex Distance 1 (MRD1)

    Time frame: Basaline

  2. Margin Reflex Distance 1 (MRD1)

    Time frame: 2 weeks postoperatively

  3. Margin Reflex Distance 1 (MRD1)

    Time frame: 3 months postoperatively

  4. Eyelid symmetry

    Time frame: Basaline

  5. Eyelid symmetry

    Time frame: 2 weeks postoperatively

  6. Eyelid symmetry

    Time frame: 3 months postoperatively

  7. Eyelid symmetry

    Time frame: 7 months postoperatively

  8. Ocular dominance

    Time frame: Basaline

  9. Hering's law dependence

    Time frame: Basaline

  10. Objective eyelid contour

    Time frame: 2 weeks postoperatively

  11. Objective eyelid contour

    Time frame: 3 moths postoperatively

  12. Objective eyelid contour

    Time frame: 7 months postoperatively

  13. Subjective eyelid contour

    Time frame: 2 weeks postoperatively

  14. Subjective eyelid contour

    Time frame: 3 months postoperatively

  15. Subjective eyelid contour

    Time frame: 7 months postoperatively

  16. Upper eyelid crease

    Time frame: 2 weeks postoperatively

  17. Upper eyelid crease

    Time frame: 3 months postoperatively

  18. Upper eyelid crease

    Time frame: 7 months postoperatively

  19. Clavien-Dindo Score

    Time frame: Intervention day

  20. Clavien-Dindo Score

    Time frame: 2 weeks postoperatively

  21. Clavien-Dindo Score

    Time frame: 3 months postoperatively

  22. Clavien-Dindo Score

    Time frame: 7 months postoperatively

  23. Reintervention

    Time frame: 3 months postoperatively

  24. Surgical success

    Time frame: 7 months postoperatively

  25. FACE-Q Upper Eyelid Assessment

    Time frame: 3 months postoperatively

  26. FACE-Q Upper Eyelid Assessment

    Time frame: 7 months postoperatively

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2028, 24 months later.

Of 25 interventional studies with no phase under Blepharoptosis, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's planned 24 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Oct 1, 2028
CompletionEst.
Oct 1, 2028
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Title
Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis: A Randomized Controlled Trial.
Oct 1, 2026
Registered
First appeared on the registry
Sep 29, 2026
Show all 2 updates
  1. Oct 1, 2026
    Title Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis: A Randomized Controlled Trial.
    + 1 other change: description
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07847749
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Responsible party
Viviana Patricia Lezcano Carduz (Medical Doctor. Ophthalmologist., Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) — Principal investigator
First posted
Sep 29, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Oct 1, 2028 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Oct 1, 2026

Study contacts

Viviana Patricia Lezcano Carduz, MD
Contact
viviana.lezcano@quironsalud.es
+34 914816225
Francisco Javier González García., MD, PhD.
Contact
Fjavier.gonzalez@hospitalreyjuancarlos.es
+34 914816225
Viviana Patricia Lezcano Carduz, MD
principal investigator · Instituto de Investigación Sanitaria- Fundación JImenez Díaz

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion